Journal
CELL REPORTS
Volume 40, Issue 3, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2022.111116
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81974437, 81472627, 82172959, 81874147]
- National Key Basic Research Program of China [2013CB911000]
- Aerospace Medical Experiment Project of Space Station [HYZHXM02002]
- Peking University Medicine Seed Fund for Interdisciplinary Research of the Fundamental Research Funds for the Central Universities [BMU2018MB002]
Ask authors/readers for more resources
The study reveals a new function of p62 in base excision repair, distinct from its known functions. Loss of p62 impairs repair capacity and increases cancer cell sensitivity to alkylating and oxidizing agents. Therefore, targeting p62 may have potential for cancer therapeutics.
p62, a well-known adaptor of autophagy, plays multiple functions in response to various stresses. Here, we report a function for p62 in base excision repair that is distinct from its known functions. Loss of p62 impairs base excision repair capacity and increases the sensitivity of cancer cells to alkylating and oxidizing agents. In response to alkylative and oxidative damage, p62 is accumulated in the nucleus,acetylated by hMOF,and deacetylated by SIRT7, and acetylated p62 is recruited to chromatin. The chromatin-enriched p62 directly interacts with APE1, a key enzyme of the BER pathway, and promotes its endonuclease activity, which facil-itates BER and cell survival. Collectively, our findings demonstrate that p62 is a regulator of BER and provide further rationale for targeting p62 as a cancer therapeutic strategy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available